The COVID-19 tally in India continued to record a massive surge with 97,894 cases being registered in a single day. While the overall tally gone beyond 5.1 million, the death toll increased from 82,066 to 83,198, according to latest data released by the Ministry of Health and Family Welfare.
Now the country’s total coronavirus case stands at 51,18,253.
— ICMR (@ICMRDELHI) September 17, 2020
According to Union health ministry update on Thursday morning, the number of active cases crossed the million mark and currently stand at 10,09,976 whereas 40,25,079 patients have been discharged from hospitals.
The recovery rate has further improved to 78.53 per cent, the health ministry said.
It further said that nearly 59 per cent of the new recoveries came from five states – 23.41 per cent from Maharashtra (19,423 recoveries); and a cumulative 35.5 per cent from Andhra Pradesh (9,628 recoveries), Karnataka (7,406), Uttar Pradesh (6,680) and Tamil Nadu (5,735).
Twenty-seven states and union territories are reporting recovery rates of more than 70 per cent, the ministry highlighted.
Meanwhile, Pune-based Serum Institute of India (SII) on Wednesday received the approval from the Drugs Controller General of India (DCGI) to resume clinical trials for the Covid-19 vaccine candidate developed by United Kingdom’s Oxford University and AstraZeneca.
The trials in India were paused last week after a trial subject in the United Kingdom developed an unexplained severe adverse reaction.
On September 16, the Supreme Court said that the central government has approved the use of Remdesivir and Fabiparivir as medicines to treat the coronavirus disease.
The top court was hearing a plea by the CBI against ten Indian pharmaceutical firms for manufacturing and selling these two medicines to treat the coronavirus disease.
Globally, nearly 30 million people have been infected with as many as 939,427 fatalities. The United States continued to the worst affected followed by India and Brazil. India, however, remained on top of the recoveries chart.